<DOC>
	<DOCNO>NCT00699361</DOCNO>
	<brief_summary>Recently literature reveal fact , show H+/K+ ATPase expression limit tot stomach . H+/K+ ATPase also find smooth muscle cell tissue ( McCabe , R.D . et al. , Am J Physiol . 1992 ) . For myocard localisation proven rat yet ( Beisvag , V. et al. , Acta Physiol Scand . 2003 ) . Moreover biochemical hint lead u highly probability myocardial H+/K+ ATPase ( Nagashima , R. et al. , Jpn Heart J . 1999 ) .</brief_summary>
	<brief_title>Influence Pantoprazole Human Myocardial Contractility Patients With Congestive Heart Failure</brief_title>
	<detailed_description>Recently literature reveal fact , show H+/K+ ATPase expression limit tot stomach . H+/K+ ATPase also find smooth muscle cell tissue ( McCabe , R.D . et al. , Am J Physiol . 1992 ) . For myocard localisation proven rat yet ( Beisvag , V. et al. , Acta Physiol Scand . 2003 ) . Moreover biochemical hint lead u highly probability myocardial H+/K+ ATPase ( Nagashima , R. et al. , Jpn Heart J . 1999 ) . Aim clinical study examine , whether proton pump inhibitor influence myocardial contraction human myocard want ascertain amount influence H+/K+ ATPase myocardial contraction . Therefore mechanism putative inhibition proton pump inhibitor focus . These finding major credit regard treatment patient congestive heart failure common proton pump inhibitor . We want find , whether intake may negative inotropic effect heart failure myocard .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>1 . Only patient older 18 year . Range 18 80 year 2 . Only cooperative patient 3 . Only patient need coronary angiography , independently study 4 . Only patient leave ventricular ejection fraction demand study protocol 5 . Only patient clinical symptom congestive heart failure , correspond New York Heart Association stage NYHA II III 6 . Only patient without oral i.v . application proton pump inhibitor 48 hour prior study catheterization 1 . Manifest severe accompany disease , despite diabetes mellitus 2 . Intravascular oral application proton pump inhibitor within last 48 hour 3 . Intake Metformin within last 24 hour 4 . Status post heart transplant 5 . Pregnancy 6 . Known intolerance pantoprazole 7. severe side effect test substance pantoprazole , well pharmacokinetic interaction CYP isoenzymes 8 . Existance side effect give pantoprazole drug information , among others disturbance blood lymphatic system , leukopenia , thrombopenia , affection gastrointestinal tract , nerve system affection , psychiatric affection , renal bladder affection 9 . Participation clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Pantoprazole</keyword>
	<keyword>congestive heart failure</keyword>
</DOC>